Neurocritical Care News

DENVER — Early initiation of treatment with ofatumumab showed sustained benefit to those with treatment-naïve relapsing multiple sclerosis, Gabriel Pardo, MD, said in this Healio video from the American Academy of Neurology annual meeting.

According to statistics reported in a recent release from Sutter Health, up to 15% of strokes are suffered by individuals aged younger than 45 years, with incidence rising.

NEW YORK — New data suggests a link between inflammation during pregnancy and postpartum anxiety among women experiencing the highest anxiety symptoms, according to a poster at the American Psychiatric Association annual meeting.

The FDA has granted orphan drug designation to a small molecule therapeutic for individuals with Fragile X syndrome.

Enveric Biosciences announced it has signed a nonbinding term sheet to out-license a class of novel psilocin prodrugs to MindBio Therapeutics, an agreement that could yield more than $66 million in sales.

A health care innovation company and a clinical-stage biotech company have announced a partnership to advance a novel apomorphine therapeutic in combination with a wearable drug delivery platform to treat Parkinson’s disease.

DENVER — Treatment with a novel therapeutic led to clinically significant improvement in cognition for young persons with Angelman syndrome, Kemi Olugemo, MD, FAAN, said in this Healio video at the American Academy of Neurology annual meeting.

DENVER — Efficacy of fumarates to treat multiple sclerosis was consistent across four racial and ethnic groups, particularly for Black, Hispanic and Asian persons, according to a poster at the American Academy of Neurology annual meeting.

DENVER — A combination therapy of ciprofloxacin and celecoxib demonstrated a favorable safety profile for those with amyotrophic lateral sclerosis, Merit Cudkowicz, MD, MSc, said in this Healio video.

Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.